Epstein-Barr virus associated B-cell lymphoproliferative disorder in CLL patients after treatment with fludarabine and cyclophosphamide followed by high-dose chemotherapy with autologous stem cell transplantation

Bone Marrow Transplantation

Volumn 31, Issue 10, 2003, Pages 951-952

  Jindra, P ^a   Koza, V ^a   Boudova L ^a   Vozobulova V ^a   Cerna K ^a   Karas, M ^a   Lysak D ^a   Svojgrova M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; PREDNISONE; VINCRISTINE;

ADULT; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; B LYMPHOCYTE; CANCER STAGING; CASE REPORT; CHROMOSOME ANALYSIS; CHRONIC LYMPHATIC LEUKEMIA; DRUG MEGADOSE; EPSTEIN BARR VIRUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; IMMUNOHISTOCHEMISTRY; KARYOTYPE; LETTER; LYMPH NODE BIOPSY; LYMPHOPROLIFERATIVE DISEASE; MALE; PRIORITY JOURNAL; SEROLOGY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; B-LYMPHOCYTES; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; VIDARABINE;

EID: 0038282631     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704026     Document Type: Letter

References (14)

1. Chao NJ, Berry GJ, Advani R et al. Epstein-Barr virus associated lymphoproliferative disorder following autologous bone marrow transplantation for non-Hodgkin's lymphoma. Transplantation 1993; 55: 1425-1428.
2. Shepherd JD, Gascoyne RD, Barnett MJ et al. Polyclonal Epstein-Barr virus-associated lymphoproliferative disorder following autografting for chronic myeloid leukemia. Bone Marrow Transplant 1995; 15: 639-641.
3. Briz M, Forez R, Regidor C et al. Epstein-Barr virus associated B-cell lymphoma after autologous bone marrow transplantation for T cell acute lymphoblastic leukemia. Br J Haematol 1998; 98: 485-487.
4. Hauke RJ, Greiner TC, Smir BN et al. Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases. Bone Marrow Transplant 1998; 21: 1271-1274.
5. Peniket AJ, Perry AR, Williams CD et al. A case of EBV-associated lymphoproliferative disease following high-dose therapy and CD34-purified autologous peripheral blood progenitor cells transplantation. Bone Marrow Transplant 1998; 22: 307-309.
6. Lones MA, Kirov I, Said Jw et al. Post-transplant lymphoproliferative disorder after autologous peripheral stem cell transplantation in a pediatric patient. Bone marrow Transplant 2000; 26: 1021-1024.
7. Niesvizky R, Zhu AX, Louie D et al. Epstein-Barr virus-associated lymphoma after treatment of macroglobulinemia with cladribine (letter) N Engl J Med 1999; 341: 55 (letter).
8. Lazzarino M, Orlandi E, Baldanti F et al. The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders. Br J Haematol 1999; 107: 877-882.
9. Tinchon C, Auner H, Linkesch W. EBV-associated lymphoproliferative disease after therapy with fludarabine in AML. Onkologie 2000; 23 (Suppl 7): 163 (abstract 0623).
10. Cheson BD, Bennett JM, Grever M et al. National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990-4997.
11. Tierney RJ, Steven A, Young L, Rickinson AB. Epstein-Barr virus latency in blood mononuclear cells:analysis of viral gene transcription during primary infection and in the carrier state. J Virol 1994; 68: 7374-7385.
12. Cinque P, Brytting M, Vago L et al. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet 1993; 342: 398-401.
13. Leporrier M, Chevret S, Cazin B et al. Randomized comparison of fludarabine, CAP, and CHOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients. Blood 2001; 98: 2319-2325.
14. Faye A, Van Den Abeele T, Peuchmaur M et al. Anti-CD20 monoclonal antibody for post-transplant lymphoproliferative disorders. Lancet 1998; 352: 1285.